Syntheses and biological activities of benzimidazolo[2,1-b] benzo[e]thiazepin-5(10H)-ones

Archiv der Pharmazie

Volumn 341, Issue 1, 2008, Pages 49-54

  Rastkari, Noushin ^a   Abdollahi, Mohammad ^a   Ahmadkhaniha, Reza ^a   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant activity; Benzothiazepine; Synthesis

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 3 HYDROXY BENZIMIDAZOLO[2,1 B]BENZO[E]THIAZEPIN 5 (10H) ONE; ANTIOXIDANT; BENZIMIDAZOLO[2,1 B]BENZO[E]THIAZEPIN 5 (10H)ONE DERIVATIVE; BENZIMISAZOLO[2,1 B]BENZO[E]THIAZEPIN 5 (10H)ONE; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; IN VIVO STUDY; INFRARED SPECTROMETRY; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; BLOOD GLUCOSE; FREE RADICAL SCAVENGERS; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZEPINES;

EID: 38949135470     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700099     Document Type: Article

References (23)

1. N. Taria, Am. J. Cardiol. 1987, 59, 24-29.
2. J. Slade, J. L. Stanton, D. S. David, G. C. Mazzenga, J. Med. Chem. 1985, 28, 1517-1520.
3. M. G. Bock, R. M. Dipardo, B. E. Evas, K. E. Kittle, et al., J. Med. Chem. 1989, 32, 13-17.
4. K. Nahed, Can. Patent. Appl. CA 2, 030, 159; 1991. (Chem. Absr. 1991, 115, 98515f.).
5. K. Nahed, Eur. Pat. Appl. EP 430, 036, 1991. (Chem Abstr. 1992, 116, 717c).
6. G. C. Yen, H. Y. Chen, J. Agric. Food Chem. 1995, 43, 27-32.
7. C. Soler, J. C. Espin, H. Wichers, Phytochem. Anal. 2000, 11, 1-7.
8. M. Ellnain, Z. Kruczynski, A. Kasprzak, Fitoterapia 2003, 74, 1-4.
9. P. C. H. Hollman, J. Sci. Food Agric. 2001, 81, 842-847.
10. M. Hatanaka, K. Takahashi, S. Nakamura, T. Mashino, Bioorg. Med. Chem. 2005, 13, 6763-6767.
11. F. Bailly, C. Maurin, E.Teissier, H. Vezin, P. Cotelle, Bioorg. Med. Chem. 2004, 12, 5611-5616.
12. J. Lertvorachon, J. P. Kim, D. V. Soldatov, J. Boyd, et al., Bioorg. Med. Chem. 2005, 13, 4627-4631.
13. S. Shahriari, N. Yasa, M. Abdollahi, Int. J. Pharmacol. 2006, 2, 646-649.
14. N. Yassa, F. Sharififar, A. Shafiee, Pharm. Biol. 2005, 43, 33-38.
15. R. Amarowicz, R. B. Pegg, B. Barl, Food Chem. 2004, 84, 551-556.
16. H. J. Lee, J. W. Seo, B. H. Lee, K. H. Chung, D. Y. Chi, Bioorg. Med. Chem. Lett. 2004, 14, 463-466.
17. I. F. Benzie, J. J. Strain, Methods Enzymol. 1999, 299, 15-27.
18. K. Satho, Clin. Chim. Acta 1978, 90, 37-43.
19. R. L. Wilson in Biochemical Mechanisms of Liver Injury, Aca demic Press, New York, 1988, pp. 123-135.
20. D. Mathe, Diabetes Metab. 1995, 21, 106-111.
21. J. A. Van Allan, B. D. Deacon in Organic Synthesis, (Ed.: N. Rabjohn), John Wiley, New York, 1963; Coll. Vol. 4, pp. 569-570.
22. D. J. Burton, W. M. Koppes, J. Org. Chem. 1975, 40, 3026-3032.
23. A. I. Vogel Text Book of Practical Organic Chemistry, Longman, London, 1986, pp. 694-697.